Dexcel Ltd.

Also on record

Records under this name other than patents Dexcel Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Dexcel Ltd.

Patent	Title	Status	Expires	Confidence
US 10,350,171	Celecoxib and amlodipine formulation and method of making the same Formerly held In force Term ends Jun 14, 2038 · From the USPTO record	In force	Term ends Jun 14, 2038	From the USPTO record
US 9,023,391	Stable Benzimidazole Formulation Term ended Ended no later than Aug 16, 2025 · Medium confidence	Term ended	Ended no later than Aug 16, 2025	Medium confidence
US 10,945,960	Celecoxib and amlodipine formulation and method of making the same Formerly held Lapsed on the fee record Ended Mar 16, 2025 · From the USPTO record	Lapsed on the fee record	Ended Mar 16, 2025	From the USPTO record
US 10,925,835	Celecoxib and amlodipine formulation and method of making the same Formerly held Lapsed on the fee record Ended Feb 23, 2025 · From the USPTO record	Lapsed on the fee record	Ended Feb 23, 2025	From the USPTO record
US 8,105,627	Extended release venlafaxine tablet formulation Lapsed on the fee record Ended Jan 31, 2024 · From the USPTO record	Lapsed on the fee record	Ended Jan 31, 2024	From the USPTO record
US 7,131,393	Selection system and method for milking animals Formerly held Term ended Term ended Jul 20, 2022 · From the USPTO record	Term ended	Term ended Jul 20, 2022	From the USPTO record
US 7,255,878	Stable Benzimidazole Formulation Term ended Term ended Dec 6, 2020 · High confidence	Term ended	Term ended Dec 6, 2020	High confidence
US 7,732,404	Pro-nanodispersion for the delivery of cyclosporin Lapsed on the fee record Ended Jun 8, 2014 · From the USPTO record	Lapsed on the fee record	Ended Jun 8, 2014	From the USPTO record
US 7,026,290	Dispersible Concentrate for the Delivery of Cyclosprin Lapsed on the fee record Ended Apr 11, 2014 · Medium confidence	Lapsed on the fee record	Ended Apr 11, 2014	Medium confidence